Shaowei Qiu

13PUBLICATIONS
33CO-AUTHORS
Haematological tumoursEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

|Apr 16, 2026
Daunorubicin-45 Vs. Daunorubicin-60 for Induction in Intermediate-Age Patients of AML: Results From a Randomized Trial.

|Aug 09, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.

Yu Liu, Wenbing Liu, Yihan Mei

|Jun 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Jun 11, 2025
Nanomaterials in stimulus-responsive drug delivery systems facilitate precise therapy for hematologic diseases.

Lingrui Li, Wei Jiang, Shaowei Qiu

|Feb 07, 2025
The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia.

Heye Yu, Wenbing Liu, Junping Zhang

Pageof 3

Frequent Collaborators

10 joint publications

Jianxiang Wang

7 joint publications

Hui Wei

5 joint publications

Ying Wang

5 joint publications

Kaiqi Liu